EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Small upconversion-ruthenium nanohybrids for cancer theranostics

Anne Nsubuga, Nour Fayad, Federico Pini, Marta M Natile, Niko Hildebrandt

Nanoscale · 2025 · 17 (7) · 3809-3821

DOI: 10.1039/d4nr04210g ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanoscale, 2025. Verfasst von Anne Nsubuga und 4 weiteren Autor:innen. Beteiligte Einrichtung: Univ Rouen, CNRS, INSA Rouen, Normandie Université, Laboratoire COBRA, 76000 Rouen, France. anne.nsubuga@univ-rouen.fr. Hauptthemen laut MEDLINE: Theranostic Nanomedicine, Ruthenium, Nanoparticles, Breast Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Horizon 2020 Framework Programme, Labex, Université de Rouen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

NIR-triggered drug release from upconversion nanoparticles functionalized with mesoporous silica shells destroys the nuclei of cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Theranostic NanomedicineRutheniumNanoparticlesBreast NeoplasmsHumansMCF-7 CellsSilicon DioxideAzo CompoundsAntineoplastic AgentsDrug CarriersDrug Delivery SystemsNeoplasms

Substanzen

RutheniumSilicon DioxideAzo CompoundsAntineoplastic AgentsazobenzeneDrug Carriers

Autor:innen und Institutionen

  • Univ Rouen, CNRS, INSA Rouen, Normandie Université, Laboratoire COBRA, 76000 Rouen, France. anne.nsubuga@univ-rouen.fr.
  • Istituto di Chimica della Materia Condensata e Tecnologie per l'Energia (ICMATE), Consiglio Nazionale delle Ricerche (CNR), Dipartimento di Scienze Chimiche, Università di Padova, 35131 Padova, Italy.
  • McMaster University, Department of Engineering Physics, Hamilton, ON M8S 4K1, Canada. hildebrandt@mcmaster.ca.

Förderung

  • Horizon 2020 Framework Programme
  • Labex
  • Université de Rouen
  • Institut National des Sciences Appliquées Rouen
  • Centre National de la Recherche Scientifique
  • European Regional Development Fund
  • Agence Nationale de la Recherche
  • Canada Excellence Research Chairs, Government of Canada

Zitieren

APA

Nsubuga, A., Fayad, N., Pini, F., Natile, M. M., & Hildebrandt, N. (2025). Small upconversion-ruthenium nanohybrids for cancer theranostics. Nanoscale, 17(7), 3809-3821. https://doi.org/10.1039/d4nr04210g

Vancouver

Nsubuga A, Fayad N, Pini F, Natile MM, Hildebrandt N. Small upconversion-ruthenium nanohybrids for cancer theranostics. Nanoscale. 2025;17(7):3809-3821. doi:10.1039/d4nr04210g

BibTeX
@article{Nsubuga2025,
  author = {Nsubuga, Anne and Fayad, Nour and Pini, Federico and Natile, Marta M and Hildebrandt, Niko},
  title = {Small upconversion-ruthenium nanohybrids for cancer theranostics},
  journal = {Nanoscale},
  year = {2025},
  volume = {17},
  number = {7},
  pages = {3809--3821},
  doi = {10.1039/d4nr04210g}
}
Kostenlos starten →